San Diego, California — According to state and local economic development sources Biocept plans to invest $3,213,906.00 to build out 37,371 square feet of new space in San Diego. The company plans to occupy the new space at 9955 Mesa Rim Rd in San Diego, on or about May 1, 2021. According to the company website Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor Cells (CTCs) and in plasma (cell free circulating tumor DNA). Our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. Our strategic focus is to promote our unique Targeted Selector technology to the Oncology Community. Our Target Selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells.

To learn more about Biocept, visit http://biocept.com/

Company Contact:
Michael Nall, Chief Executive Officer
mnall@biocept.com
https://www.linkedin.com/in/michael-nall-b06808b/
858-320-8200

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved